Culture-dependent evaluation of the respiratory microbiome in children with cystic fibrosis

Keywords: cystic fibrosis, microbiome, minor colony variants, mucoid phenotype, resistance


The study aimed to assess the regional peculiarities of the respiratory profile of children with cystic fibrosis (CF) in the Dnipro region (Ukraine).

Methods. Children living in the Dnipro region and aged younger than 18 years old with molecular-genetic confirmation of CF were enrolled in the study. Lung colonization was evaluated using a culture-dependent method. Sputum, mucus from the posterior pharyngeal wall and bronchoalveolar lavage fluid (BALF) were utilized.

Results. The Firmicutes phylum was the most common and occupied 54.00 % of the general proportion. On the other hand, the Proteobacteria phylum demonstrated overexpression in CF airways and kept the second rank with 28.87 %.

Sorensen's species similarity coefficient showed an allied affinity between the microbial burden of oropharyngeal samples with nasopharyngeal and sputum, QS = 0.61 and 0.91, respectively. However, the species composition within the nasal cavity was distinct from sputum and BALF (QS=0.47).

The primary pathogens in childhood were S. aureus, H. influenza, P. aeruginosa and A. fumigatus. In contrast to gram-negative non-fermenters (GNNF), the prevalence of S. aureus isolates by age had a non-linear character. The commensal microbiota changed negatively with age. Among children under 12 years, the Streptococcus genus was identified in 23.08 % of the samples, but among the age category older than 15 – only in 9.22 %.

11.06 % of S. aureus had small colony variants (SCVs) morphotypes. Isolates of P. aeruginosa with the properties of SCVs were also found in children who underwent prolonged antimicrobial treatment. However, the most prominent was the mucoid phenotype – 34.31 % of isolates.

Conclusions. Along with conventional microbiological properties, obligate pathobionts in children with CF exhibited changes, resulting in difficulties in identification. These included auxotrophic modification into SCVs and mucoid transformation.

The culture-dependent technique gives crucial data about the profile of pathogens usually associated with CF, although it is sufficiently limited


Download data is not yet available.

Author Biographies

Oksana Ishchenko, Dnipro State Medical University

Department of Microbiology, Virology, Immunology and Epidemiology

Iryna Koshova, Dnipro State Medical University

Department of Microbiology, Virology, Immunology and Epidemiology

Tetiana Krushinska, Dnipro State Medical University

Department of Microbiology, Virology, Immunology and Epidemiology

Iryna Kolesnikova, Bogomolets National Medical University

Department of Epidemiology

Dmytro Stepanskyi, Dnipro State Medical University

Department of Microbiology, Virology, Immunology and Epidemiology


Lynch, S. V., Bruce, K. D. (2013). The Cystic Fibrosis Airway Microbiome. Cold Spring Harbor Perspectives in Medicine, 3 (3), a009738–a009738. doi:

Gilpin, D., Hoffman, L. R., Ceppe, A., Muhlebach, M. S. (2021). Phenotypic characteristics of incident and chronic MRSA isolates in cystic fibrosis. Journal of Cystic Fibrosis, 20 (4), 692–698. doi:

Cuthbertson, L., Walker, A. W., Oliver, A. E., Rogers, G. B., Rivett, D. W., Hampton, T. H. et. al. (2020). Lung function and microbiota diversity in cystic fibrosis. Microbiome, 8 (1). doi:

Françoise, A., Héry-Arnaud, G. (2020). The Microbiome in Cystic Fibrosis Pulmonary Disease. Genes, 11(5), 536. doi:

Scialo, F., Amato, F., Cernera, G., Gelzo, M., Zarrilli, F., Comegna, M. et. al. (2021). Lung Microbiome in Cystic Fibrosis. Life, 11 (2), 94. doi:

Burns, J. L., Rolain, J.-M. (2014). Culture-based diagnostic microbiology in cystic fibrosis: Can we simplify the complexity? Journal of Cystic Fibrosis, 13 (1), 1–9. doi:

Royal Brompton Hospital Paediatric Cystic Fibrosis Team. Clinical guidelines: Care of children with cystic fibrosis (2022). Medicines Management Board of Royal Brompton & Harefield NHS Foundation Trust 2020, 311.

Cornaglia, G., Courcol, R., Hermann, J.-L. et. al. (2011). ESCMID: European Manual of Clinical Microbiology.

Yadav, S. K., Singh, S., Gupta, R. (2019). Biomedical Statistics. A Beginner's Guide. Singapore: Springer, 342. doi:

Sait, L., Galic, M., Strugnell, R. A., Janssen, P. H. (2003). Secretory Antibodies Do Not Affect the Composition of the Bacterial Microbiota in the Terminal Ileum of 10-Week-Old Mice. Applied and Environmental Microbiology, 69 (4), 2100–2109. doi:

Thornton, C. S., Surette, M. G. (2021). Potential Contributions of Anaerobes in Cystic Fibrosis Airways. Journal of Clinical Microbiology, 59 (3). doi:

Frayman, K. B., Armstrong, D. S., Grimwood, K., Ranganathan, S. C. (2017). The airway microbiota in early cystic fibrosis lung disease. Pediatric Pulmonology, 52 (11), 1384–1404. doi:

Hardy, B. L., Merrell, D. S. (2021). Friend or Foe: Interbacterial Competition in the Nasal Cavity. Journal of Bacteriology, 203 (5). doi:

Krishnakumari, V., Guru, A., Adicherla, H., Nagaraj, R. (2018). Effects of increasing hydrophobicity by N‐terminal myristoylation on the antibacterial and hemolytic activities of the C‐terminal cationic segments of human‐β‐defensins 1–3. Chemical Biology & Drug Design, 92 (2), 1504–1513. doi:

Bhagirath, A. Y., Li, Y., Somayajula, D., Dadashi, M., Badr, S., Duan, K. (2016). Cystic fibrosis lung environment and Pseudomonas aeruginosa infection. BMC Pulmonary Medicine, 16 (1). doi:

Clunes, M. T., Boucher, R. C. (2007). Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorder. Drug Discovery Today: Disease Mechanisms, 4 (2), 63–72. doi:

Martín-Gómez, M. T. (2020). Taking a look on fungi in cystic fibrosis: More questions than answers. Revista Iberoamericana de Micología, 37 (1), 17–23. doi:

Singh, A., Ralhan, A., Schwarz, C., Hartl, D., Hector, A. (2017). Fungal Pathogens in CF Airways: Leave or Treat? Mycopathologia, 183 (1), 119–137. doi:

Poore, T. S., Hong, G., Zemanick, E. T. (2021). Fungal Infection and Inflammation in Cystic Fibrosis. Pathogens, 10 (5), 618. doi:

Goddard, A. F., Staudinger, B. J., Dowd, S. E., Joshi-Datar, A., Wolcott, R. D., Aitken, M. L. et. al. (2012). Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proceedings of the National Academy of Sciences, 109 (34), 13769–13774. doi:

Hector, A., Jonas, F., Kappler, M., Feilcke, M., Hartl, D., Griese, M. (2009). Novel Method to Process Cystic Fibrosis Sputum for Determination of Oxidative State. Respiration, 80 (5), 393–400. doi:

Sibley, C. D., Grinwis, M. E., Field, T. R., Eshaghurshan, C. S., Faria, M. M., Dowd, S. E. et. al. (2011). Culture Enriched Molecular Profiling of the Cystic Fibrosis Airway Microbiome. PLoS ONE, 6 (7), e22702. doi:

Caballero, J. de D., del Campo, R., Tato, M., Gómez G de la Pedrosa, E., Cobo, M., López-Causapé, C. et. al. (2014). Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices. doi: BMC Microbiology, 14 (1).

Culture-dependent evaluation of the respiratory microbiome in children with cystic fibrosis

👁 38
⬇ 38
How to Cite
Ishchenko, O., Koshova, I., Krushinska, T., Kolesnikova, I., & Stepanskyi, D. (2022). Culture-dependent evaluation of the respiratory microbiome in children with cystic fibrosis. EUREKA: Health Sciences, (4), 39-49.
Medicine and Dentistry